Novel application of Danhong blood stasis dispersing composition
A technology of Danhong removing blood stasis and composition, which is applied in the application field of Danhong removing blood stasis composition as a histone deacetylase agonist, and achieves the effects of fast onset time and exact effect.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0028] Example 1: Research on the role of DHK in regulating SIRT1 / NF-κB signaling pathway
[0029] 1. Experimental animals: SPF grade SD rats; half male and half male; 30 rats in total; 250-280g
[0030] 2. Experimental drugs and instruments:
[0031] Normal saline (Foshan Double Crane Pharmaceutical Co., Ltd.), xylazine injection (Jilin Province Huamu Animal Health Products Co., Ltd.), pentobarbital sodium (Merck, Germany), ceftriaxone sodium for injection (Shenzhen Li Jian Pharmaceutical Co., Ltd.), 2% lidocaine hydrochloride (Hubei Tianyao Pharmaceutical Co., Ltd.), rat CRP ELISA kit (Nanjing Jiancheng Company), rat IL-1β ELISA kit (American eBioscience Company), rat TNF-αELISA Kit (Lianke Biotechnology Co., Ltd.), Rat PAI-1 ELISA Kit (UK Abcam Company), Rat tPA ELISA Kit (UK Abcam Company), BCA Protein Detection Kit (Converse Century Co., Ltd.) , Anti-SIRT1antibody (abcam company), Anti-Akt antibody (CST company), Anti-p-Akt antibody (CST company), Anti-p65antibody (CST ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com